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Abstract
Background: Dietary non-digestible carbohydrates stimulate the gut microflora and are therefore
presumed to improve host resistance to intestinal infections. However, several strictly controlled
rat infection studies showed that non-digestible fructo-oligosaccharides (FOS) increase, rather than
decrease, translocation of Salmonella towards extra-intestinal sites. In addition, it was shown that
FOS increases intestinal permeability already before infection. The mechanism responsible for this
adverse effect of FOS is unclear. Possible explanations are altered mucosal integrity due to changes
in tight junctions or changes in expression of defense molecules such as antimicrobials and mucins.
To examine the mechanisms underlying weakening of the intestinal barrier by FOS, a controlled
dietary intervention study was performed. Two groups of 12 rats were adapted to a diet with or
without FOS. mRNA was collected from colonic mucosa and changes in gene expression were
assessed for each individual rat using Agilent rat whole genome microarrays.
Results: Among the 997 FOS induced genes we observed less mucosal integrity related genes than
expected with the clear permeability changes. FOS did not induce changes in tight junction genes
and only 8 genes related to mucosal defense were induced by FOS. These small effects are unlikely
the cause for the clear increase in intestinal permeability that is observed. FOS significantly
increased expression of 177 mitochondria-related genes. More specifically, induced expression of
genes involved in all five OXPHOS complexes and the TCA cycle was observed. These results
indicate that dietary FOS influences intestinal mucosal energy metabolism. Furthermore, increased
expression of 113 genes related to protein turnover, including proteasome genes, ribosomal genes
and protein maturation related genes, was seen. FOS upregulated expression of the peptide
hormone proglucagon gene, in agreement with previous studies, as well as three other peptide
hormone genes; peptide YY, pancreatic polypeptide and cholecystokinin.
Conclusion: We conclude that altered energy metabolism may underly colonic barrier function
disruption due to FOS feeding in rats.
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Background
Non-digestible carbohydrates like fructo-oligosaccharides
(FOS) stimulate the gut microflora and are therefore pre-
sumed to improve host resistance to intestinal infections.
For this reason non-digestible carbohydrates are added to
a growing list of products, including baby-formula, bread,
dairy products. Many studies, including our own, showed
that non-digestible carbohydrates indeed affect intestinal
microflora composition [1-3]. However, there is little evi-
dence that these non-digestible carbohydrates strengthen
intestinal resistance to infection and gut barrier function.
For this reason, several strictly controlled rat infection
studies were previously performed at our lab. These stud-
ies consistently showed that the non-digestible carbohy-
drates inulin, lactulose and FOS increase translocation of
Salmonella to extra-intestinal organs [3-5]. A dose-depend-
ent increase in Salmonella translocation was observed in
FOS-fed rats [3]. Stimulation of Salmonella translocation
by dietary FOS was reflected in transcriptional changes in
colon. Genes involved in antimicrobial defense, immune
response and inflammation were induced by Salmonella
infection of rats on a control diet and further upregulated
in Salmonella infected rats on a FOS diet [6]. Moreover,
intestinal barrier parameters were already affected by FOS
before infection. In particular intestinal permeability was
increased by FOS before Salmonella challenge. Also, lumi-
nal cytotoxicity and faecal mucin excretion were increased
in FOS-fed rats and may indicate mucosal irritation [5].
The intestinal barrier is mainly formed by the mucosal
epithelial lining. Disturbed barrier function can be moni-
tored by measurement of epithelial permeability using
inert permeability markers such as different kind of sugars
or CrEDTA [7,8]. It has been shown that increased trans-
port of large molecules or antigens due to increased per-
meability may initiate inflammation [9]. Several
mechanisms have been implicated in the mucosal barrier.
Tight junctions tightly connect the epithelial cells and reg-
ulate paracellular transport of fluids, electrolytes and
small compounds [10]. Modification or cellular transloca-
tion of the tight junction molecules ZO1 and several clau-
dins have indeed been observed in inflammatory bowel
disease (IBD) and chronic non-steroidal anti-inflamma-
tory drugs (NSAIDs) use, both characterized by increased
intestinal permeability [11,12].
In addition to changes in epithelial tight junctions, bal-
ance between apoptosis and proliferation, or regenera-
tion, is also a major determinant of an intact mucosal
epithelial lining [13]. Increased apoptosis can induce epi-
thelial leakage as shown in colonic epithelial cell lines and
in intestinal biopsy specimens of IBD patients [14].
Apart from tight junctions and apoptosis, secretory prod-
ucts of intestinal epithelial cells are known to play a role
in mucosal barrier. The different intestinal epithelial cells;
enterocytes, goblet cells, Paneth cells and enteroendocrine
cells, are equipped with defense mechanisms. For instance
Paneth cells in the crypt base produce antimicrobials,
such as defensins, lysozyme and Pla2g2a [15], to regulate
and restrict the bacterial load in the gut lumen. Goblet
cells produce mucins to form a mucus layer, this layer
functions as a physical barrier that protects the epithelial
cells from harmful compounds [16]. Furthermore, the
immune system plays an important role in mucosal integ-
rity [17]. Whether other processes are involved and the
relative importance of these mechanisms for intestinal
barrier integrity is not known. Also it is not known if any
of the above mentioned mechanisms or others are respon-
sible for the effect of FOS on gut permeability.
Therefore, we analyzed colonic gene expression changes
in individual rats fed a 6% FOS diet for 2 weeks. Analyzing
FOS induced gene expression using whole genome micro-
arrays allowed us to not only focus on the above men-
tioned mechanisms, but to obtain an unbiased view on
processes affected by dietary FOS. This facilitates identifi-
cation of genes and processes currently unknown to be
related to barrier function. The colon had our main inter-
est as FOS and other non-digestible carbohydrates are
exclusively fermented in the distal gut in humans [18] and
rats [3]. We aimed to identify the in vivo biological mech-
anisms involved in FOS-induced weakening of the barrier
in rats.
Results
Food intake, body weight gain, and intestinal permeability
Rats on the control diet and FOS diet showed no signifi-
cant difference in body weight gain. Both dietary groups
consumed the provided 14 grams of diet per day as
intended and thus had a similar dietary CrEDTA intake.
Intestinal permeability was examined by measurement of
CrEDTA excretion in urine and showed that FOS fed rats
had increased urinary excretion of this inert permeability
marker as compared to the control group (Figure 1).
Gene expression profile
28180 probes on the array had an expression value of 1.5
times above background. Of these 123 were induced and
56 were reduced more than 1.5 fold in FOS fed rats com-
pared with rats fed the control diet. Only 19 probes were
induced more than 2-fold. While gene expression changes
induced by FOS supplementation were small, there were
many significantly changed probes in the dataset: 803 had
a p-value < 0.001, and 231 probes had a FDR derived q-
value < 0.01. This indicated that the gene expression
response of colon mucosa to FOS was small in magnitude,
but highly significant. As each probe signal is tested inde-BMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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pendently in t-test and multiple testing increases the risk
for finding false positives, we also applied Random Forest
[19,20]. RF ranks genes based on an importance value tak-
ing main treatment effect as well as gene-gene interaction
into account [20]. Using RF, we identified 935 probes
with an importance value above threshold. 629 were
selected by both the t-test and RF. To prevent loss of infor-
mation, we used all genes selected by t-test and RF. This
resulted in a list of 1109 probes. 112 corresponding genes
were listed more than once. Therefore, duplicates with the
highest p-values were removed, resulting in 997 unique
genes regulated by FOS
Gene selection by t-test or RF alone substantially over-
lapped and did result in a highly comparable outcome in
pathway analysis, showing that the main effects extracted
by both methods were similar. However, the individual
gene selection differed slightly between both methods.
We choose to include all genes selected by either method.
Effect of FOS on the expression of barrier associated genes
As FOS affects the mucosal barrier, we specifically ana-
lyzed genes that are known or assumed to play a role in
barrier function. These include tight junction genes like
Zo-1, occludin and claudin, cell turnover/apoptosis genes
such as caspases, Bak, Bcl-2, and mucosal defense genes
such as defensins, lipocalin, toll like receptors and IgA
(Additional file 1). Tight junction related genes were not
affected by FOS. Several apoptosis (for example Bax,
DNase1, Pdcd 6 & 8) and mucosal defense genes (for
example phospholipase A2 and trefoil factor 1 & 3) were
increased by FOS (Additional file 1). However, no FOS
effect was found on other mucosal defense genes like IgA,
Mucin 2 & 3, defensins, lipocalin, calprotectin, and most
toll-like receptors. In addition, some markers of apoptosis
were slightly affected (Bak, Caspase 7), while most
(including Apaf, Caspase 9, caspase 3, caspase 2, Bcl2 and
Bad) were not affected by FOS.
Genes most prominently affected by FOS
We examined the top 10 of genes most affected by the FOS
diet (Table 1). We choose the genes most prioritized by
RF. These genes were characterized by extremely low p-
values and relatively high fold changes. The genes were
related to nutrient homeostasis (proglucagon), energy
metabolism (NADH dehydrogenases (Ndufb6, Ndufa4
and Ndufb5) and ATP synthase (Atp5f1)), protein turnover
(Proteasome subunit alpha type 3-like (Psma3l)), oxida-
tive stress response (Metallothionein-2 (Mt-2)) and reti-
nol metabolism (cellular retinol-binding protein (Rbp7)).
This top-10 list indicates that FOS especially affects cellu-
lar energy metabolism in rat colonic mucosa, this was sup-
ported by the pathway analysis results, as described
below.
Average urinary CrEDTA excretion in the control and FOS  group Figure 1
Average urinary CrEDTA excretion in the control and FOS 
group. Daily dietary CrEDTA intake was 54 µmol. Urines 
were collected at days 14 and 15. Results are expressed as 
mean ± SEM (n = 6 per diet group). The FOS group signifi-
cantly differed from the control group (***p < 0.001).
Table 1: Top 10 of highest ranked genes by t-test and Random Forest.
Gene name Sequence ID Gene Symbol Fold change* p value
Glucagon gene, exon 6 K02813 Glc 2.6 5E-10
Cellular retinol-binding protein 7 P02696 Crbp 4.0 2E-09
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 XM_215544 Ndufb5 1.3 3E-08
Unknown (LOC295337) XM_215660 - 1.6 4E-08
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 XM_216378 Ndufb6 1.5 7E-08
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 NM_134365 Atp5f1 1.4 3E-07
Protein C11orf10, LOC309206 XM_219574 - 1.4 3E-07
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 NM_010886 Ndufa4 1.4 3E-06
Metallothionein-2 BF556648 Mt2 1.9 4E-06
Proteasome subunit alpha type 3-like BN000326 Psma3l 1.4 7E-06
*Fold change FOS/controlBMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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Pathway analysis
Pathway analysis identified processes most affected by
dietary FOS in colonic mucosa. 366 Genes of the 997
selected genes could be classified based on GO term or
based on GeneGo annotation in the Metacore database
[21]. The most significant processes were an entire range
of mitochondria related processes such as mitochondrial
electron transport, oxidative phosphorylation, translation
in mitochondria and proteins targeted to mitochondria
(Additional file 2). Another highly classified process was
proteolysis (Additional file 2). To prevent bias in biologi-
cal interpretation due to gene selection (by t-test and RF),
we also applied Gene Set Enrichment Analysis (GSEA)
which includes all genes in the dataset (28180 genes). We
focused on curated gene-sets originating from GenMapp,
Biocarta, SigmaAldrich and Broad institute. Comparable
biological processes were found by GSEA as observed in
Metacore: again oxidative phosphorylation was most sig-
nificant, followed by proteasomal degradation (Addi-
tional file 3). Thus the threshold based Metacore analysis
and the threshold free enrichment analysis, GSEA, gave
similar results for the most significantly changed proc-
esses by FOS. The results obtained by pathway programs
consist of many overlapping pathways. We combined
pathways with overlapping genes such as mitochondrial
electron transport (Metacore), electron transport (Meta-
core) and electron transport chain (GSEA) and catego-
rized the processes.
Analysis based on pathway programs is restricted to the
well annotated genes [22]. As only 36% of the Agilent
whole genome array is recognized by Metacore and only
35% by GSEA, we manually extended the significantly
altered pathways with the non-recognized genes using lit-
erature and databases mining (using Biocarta, Source,
Genecards). This strengthened the pathway outcome, as
we were able to identify many additional genes affected by
FOS that could be added to the processes already identi-
fied by the pathway programs. This was the case for tran-
scription identified by Metacore as nucleosome assembly,
cell turnover identified by GSEA as programmed cell
death, cytoskeleton and vesicle related processes (muscle
filament sliding and cytoskeleton-dependent intracellular
transport in Metacore) and oxidative stress (free radical
induced apoptosis in GSEA) (Figure 2). In addition, we
identified FOS affected genes that were not grouped into
a pathway by both programs but obviously belong to the
same biological process, this was the case for mucosal bar-
rier, transport, and peptide hormones (Figure 2).
Detailed analysis of the mitochondrial processes showed
an increased expression of genes associated with al five
complexes of the OXPHOS complex, TCA-cycle and mito-
chondrial ribosomes and mitochondrial protein transport
(Table 2). In addition to protein degradation, which was
found in the pathway programs, protein translation and
maturation were also affected by FOS. From these 113
Classification of the genes affected by FOS into biological processes Figure 2
Classification of the genes affected by FOS into biological processes. Analyzed by Metacore, GSEA and data mining.BMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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genes more than 90% showed increased expression upon
FOS indicating increased protein turnover (Table 2).
Detailed gene expression data for all processes mentioned
in Table 2 is presented in Additional file 4.
Confirmation of array results by Q-PCR
Confirmation of FOS induced processes was performed
by Q-PCR. Genes from several FOS affected processes
were analyzed by individual Q-PCR. We selected nine
genes from mitochondria related processes: NADH dehy-
drogenase (ubiquinone) 1 beta subcomplex 9 (Nduf9b),
succinate dehydrogenase complex subunit B (Sdhb), ubiq-
uinol-cytochrome c reductase binding protein (UbiqcytC),
cytochrome c oxidase subunit VIIb (Cox7b), ATP synthase
H+  transporting mitochondrial F0 complex subunit G
(ATP5g), aldo-keto reductase family 1 member B8
(Akr1b8), malic enzyme 1 (Me1), mitochondrial ribos-
omal protein S16 (RiboS16), translocase of inner mito-
chondrial membrane 8 homolog b (Timm8b). In addition,
one gene from protein degradation proteasome subunit
alpha type 3-like (Psma3l), two genes related to mucosal
barrier phospholipase A2, group IIA (platelets synovial
fluid) (Pla2g2a) and trefoil factor 3 (Tff3) and one gene
from the peptide hormones, proglucagon (Gcg) were ana-
lyzed. We additionally selected retinol binding protein 7
(Rbp7) as this gene was highest induced by FOS (4-fold).
Q-PCR fully confirmed the microarray data (table 3). The
p-value in the Q-PCR analysis reached significance (p <
0.05) for 11 out of 13 genes. Two genes had a p-value >
0.05 (ATP5g and Timm8b).
Confirmation of gene expression results on protein level
To substantiate the FOS induced transcriptional modula-
tion of mitochondrial genes at the protein level, we ana-
lyzed pooled mucosal scrapings of all rats (n = 12 per
group). The small increase in mRNA levels of complex IV
subunits (~1.4 fold), was confirmed by a similar increase
(1.5, 1.7 and 2.7 fold in independent pools, relative to
actin) in protein levels of complex IV subunit COX II in
the FOS group compared with the control group in
pooled (n = 12) mucosal scrapings (Figure 3).
The relatively high and significant induction of progluca-
gon gene by FOS was also examined at the protein level.
Mucosal scrapings of randomly sampled control and FOS-
fed rats (n = 7 per group) were analyzed for GLP-1 protein
levels by western blot and normalized to actin. FOS signif-
icantly increased GLP-1 protein levels in colonic mucosal
tissue (Figure 4), substantiating the gene expression find-
ings.
Table 2: Detailed classification of biological processes affected by FOS.
Biological process Number of genes affected by FOS*
Mitochondria Complex I 27
Complex II 5
Complex III 2
Complex IV 13
Complex V 21
Metabolism and TCA cycle 53
Mitochondrial ribosomes 33
Protein transport 11
Miscellaneous 12
Protein turnover Protein degradation 31
Translation 44
Protein maturation 32
Miscellaneous 6
Transcription Chromatin related 22
mRNA metabolism 7
Transcription 26
Miscellaneous 6
Cell turnover Apoptosis 19
Growth/Differentiation 16
Mucosal barrier 30
Cytoskeleton 26
Transport 20
Oxidative stress 16
Vesicle related 10
Peptide hormones 6
Other† 503
997
* Genes with p-value < 0.001 or selected by RF threshold
† Genes with less than 5 other genes belonging to the same process, unknown genes and, genes not part of a known process.BMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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Discussion
The CrEDTA results showed that dietary FOS increased
intestinal permeability in rats in accordance with our pre-
vious study [5]. The FOS induced increase in intestinal
permeability reduces intestinal barrier function as
reported earlier [5]. We focused on the colon since fer-
mentation of FOS occurs in cecum and colon and is very
limited in the ileum [18,23]. Furthermore, by additional
Table 3: Q-PCR confirmation of microarray data.
Micro-array Q-PCR
Gene name Gene symbol Sequence ID Ratio* Ratio* SEM ± p-value†
Mitochondria
Complex I
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 Nduf9b XM_216929 1.47 1.29 0.05 0.001
Complex II
Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) Sdhb XM_216558 1.43 1.32 0.05 <0.001
Complex III
Ubiquinol-cytochrome c reductase binding protein Uqcrb XM_001074024 1.53 1.28 0.05 0.005
Complex IV
Cytochrome c oxidase subunit VIIb Cox7b NM_182819 1.61 1.36 0.06 0.001
Complex V
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G ATP5g XM_001075306 1.52 1.15 0.05 0.11
Metabolism and TCA cycle
Aldo-keto reductase family 1, member B8 Akr1b8 NM_173136 2.13 2.15 0.22 0.006
Malic enzyme 1 Me1 1.65 1.76 0.11 <0.001
Mitochondrial ribosomes
Mitochondrial ribosomal protein S16 Mrps16 XM_001064095 1.43 1.20 0.05 0.03
Mitochondrial protein transport
Translocase of inner mitochondrial membrane 8 homolog b Timm8b NM_022541 1.45 1.19 0.06 0.09
Protein turnover
Proteasome subunit alpha type 3-like Psma31 BN000326 1.39 1.24 0.04 0.002
Mucosal barrier
Phospholipase A2, group IIA (platelets, synovial fluid) Pla2g2a NM_031598 3.73 4.70 0.87 0.03
Trefoil factor 3 Tff3 NM_013042 1.7 1.21 0.05 0.04
Top 10 gene
Retinol binding protein 7 Rbp7 XM_575960 2.06 3.72 0.36 <0.001
Peptide hormone
Proglucagon Gcg NM_012707 2.56 2.91 0.23 <0.001
* Ratio FOS diet/Control diet.
± SEM of Q-PCR data is given (n = 12 per group)
† p-value of Q-PCR data is given, the p-value of microarray data were all <0.001.
Mucosal scrapings (pool of n = 12 per group) were examined for complex IV subunit COXII protein levels Figure 3
Mucosal scrapings (pool of n = 12 per group) were examined for complex IV subunit COXII protein levels. The experiment 
was performed three times with independent, pools, showing a 1.5; 1.7 and 2.7 fold difference in COXII protein expression rel-
ative to Actin, respectively. The 1.5 fold increase is shown.BMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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use of lactulose/mannitol as permeability labels [24] we
found that FOS increased intestinal permeability in the
large intestine and not in the small intestine (unpublished
results). Individual colonic gene expression of 12 rats after
≈2 weeks FOS versus control feeding were explored on
whole genome level and showed that the increased per-
meability could not be explained by changes in genes
belonging to the tight junction system in the colon. No
significant changes were observed in claudin 2 and 4, cad-
herins or tight junction protein 1. With our focus on gene
expression, possible changes in protein levels and cellular
localization or modification cannot be excluded. 19
Genes related to apoptosis were affected by FOS with only
modest fold changes. Although some pro-apoptotic genes
were mildly affected (eg Bax, Caspase 7), no changes were
seen in many key pro-apoptotic genes such as Bad, Cas-
pase 3 and Apaf1. Therefore, we feel that apoptosis is not
the main cause of the increased intestinal permeability
observed. Known mucosal defense genes such as
defensins, mucins and calprotectin were also unaffected
by FOS. These few and small transcriptional changes in
potential barrier related genes cannot explain the pro-
found and consistent effects of FOS on intestinal permea-
bility in rats. We can not fully exclude that dilution of
specific cell types in the heterogeneous cell population of
mucosal scrapings has lead to undetectable levels of some
expected genes, e.g. mucin genes. This could be further
assessed by laser microcapture dissection, which allows
isolation of specific cell types from the intestine [25], and
subsequent gene expression analysis by Q-PCR. On the
other hand, we identified multiple genes associated with
energy metabolism (177 mitochondria related genes) that
were significantly modified by FOS. Protein turnover was
also clearly affected by FOS (113 genes). Coincidence of
increased permeability and upregulation of these genes
suggests that these processes play a major role in preserva-
tion of intestinal mucosal integrity.
The most striking observation was the induction of a
broad range of mitochondrial genes. Increased expression
of mitochondrial genes is commonly observed during dis-
turbed ATP homeostasis caused by increased energy
demand or decreased mitochondrial energy supply [11-
14]. Most of the genes reported to be changed by dis-
turbed ATP homeostasis were also induced by FOS (Ant,
24 NADH dehydrogenases, 7 Cox  subunits and 3
ATPases). This could be confirmed at protein level for
complex IV subunit II. Together this strongly suggests that
FOS caused ATP depletion in colonic epithelial cells.
The increase in mitochondrial genes could indicate a com-
pensation for possible SCFA – induced ATP depletion. The
validity of this assumption could be studied by measuring
ATP levels in enterocytes of FOS- and control-fed rats. The
clear changes of FOS on mitochondrial processes were not
expected beforehand, therefore no precautions were taken
at the time of sampling and storage of the mucosal scrap-
ings that would allow post-hoc analysis of ATP levels.
Alternatively we attempted to examine levels of phospho-
rylated AMP-activated protein kinase (AMPK) as this
reflects the ADP/ATP ratio in cells [26]. Low levels of total
AMPK protein could be detected in colonic scrapings
without difference between control and FOS (data not
shown). However, AMPK phosphorylation could not be
detected in mucosal scrapings, most certainly because of
instability of the phosphorylated protein requiring spe-
cific sample collection procedures. In addition it would be
interesting to study the effects of FOS on mitochondria
using electron microscopy studies [27].
So, the question remains whether the strongly and
broadly increased expression of mitochondrial genes by
FOS, is associated with the observed increase in intestinal
permeability in FOS-fed rats. Many studies using epithe-
lial cell lines have shown that paracellular hyperpermea-
bility is caused by ATP depletion [28-30]. Another strong
indication that mitochondria are important in maintain-
ing intestinal permeability is derived from studies on
chronic NSAIDs [31]. Direct exposure of rat intestine to
the NSAID indomethacin or the mitochondrial uncoupler
DNP increases epithelial permeability [32-34], which
increased bacterial translocation in rats and intestinal cell
lines, and increased immune cell infiltration and ulcera-
tion in rats [32,35]. Enhanced bacterial translocation
reflects impaired barrier function.
In Figure 5, we schematically describe a possible mecha-
nism of the FOS induced increase in intestinal mitochon-
Relative expression of Proglucagon mRNA (gray bar) and  GLP-1 protein (black bar) in colonic mucosa of a random  selection of control fed and FOS fed rats Figure 4
Relative expression of Proglucagon mRNA (gray bar) and 
GLP-1 protein (black bar) in colonic mucosa of a random 
selection of control fed and FOS fed rats. mRNA and protein 
levels were normalized to Actin levels. Expression is shown 
as means ± SEM (n = 7). **p < 0.01, ***P < 0.001BMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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drial gene expression, the proposed ATP-depletion and
the increased mucosal permeability observed.
Previous studies in rats [3,36,37] and humans [38]
showed rapid fermentation of FOS in cecum and colon by
the endogenous microflora resulting in lactic acid accu-
mulation, SCFA production, and decreased pH of luminal
contents. Although luminal production of modest quanti-
ties of SCFAs is essential for normal colonic mucosal func-
tion [39], overproduction or accumulation of SCFA along
with low pH in the intestinal lumen has been shown to
cause intestinal injury leading to increased intestinal per-
meability in vivo [40-42] and in vitro [43,44]. Studies in
liver show that SCFA induced depletion of cellular ATP
coincided with a reduced intracellular pH (pHi) [45]. A
likely explanation for reduced pHi by SCFA is that in an
acidic luminal environment, a relatively larger portion of
SCFA becomes protonated, facilitating passive diffusion
of SCFA across the apical hydrophobic enterocyte mem-
brane causing intracellular acidification [46,47]. The
above mentioned studies were done in vitro or in perfused
liver, but the concentrations applied can impair the pHi
homeostasis in colonocytes in FOS fed rats [36,48]. Taken
together, FOS reduce luminal pH and increase levels of
SCFAs, likely leading to acidification of the cellular cyto-
plasm (decrease in pHi). A decrease in pHi is compensated
by H+ excretion in exchange for Na+ by the pHi regulating
Na+/HCO3-  cotransporter (NBC) and the Na+/H+
exchanger (NHE) in the basolateral membrane [49,50].
This indirectly activates the Na+,K+-ATPase (ATP1) which
is known to require ~25% of the cellular ATP turnover
under basal conditions [51]. Long-term exposure of ente-
Proposed mechanism of dietary FOS induced intestinal permeability Figure 5
Proposed mechanism of dietary FOS induced intestinal permeability. 1 High levels of FOS fermentation products 
increase intestinal permeability in vivo [5, 40, 41]. 2 Excess SCFAs cause intracellular acidification of epithelial cells. When pro-
tonated-SCFA diffuse from the gut lumen into epithelial cells [47, 84]. The SCFA cause intracellular acidification and induce 
proton pump activity (NHE and NBC transporters) which may lead to ATP depletion [43, 45]. 3 Reduced ATP levels, by 
increased energy demand, chronic mitochondrial uncoupling or any other cause of disturbed energy metabolism, are compen-
sated by increased mitochondrial gene expression and mitochondrial biogenesis [27, 85]. 4 Disturbed energy metabolism leads 
to increased permeability. In agreement: ATP-depletion in epithelial cell lines causes paracellular hyperpermeability [28-30] and 
uncoupling of intestinal mitochondria leads to increased bacterial translocation, immune cell infiltration and ulceration in rats 
[31, 32]. Calcium supplementation of a FOS diet counteracts FOS induced intestinal permeability. Calcium prevents acidifica-
tion of intestinal contents during fermentation and thus formation of protonated-SCFA.BMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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rocytes to high SCFA concentrations under low pH condi-
tions might therefore disturb or exhaust plasma
membrane pumps, leading to rapid ATP-depletion [43].
FOS diet significantly increased expression of Atp1b1 (1.2-
fold, p < 0.001). No changes were found in the gene
expression of the transporters Nbc and Nhe, but increased
activity of these transporters can occur without concomi-
tant changes in mRNA gene expression.
A strong indication supporting SCFA and low luminal pH
as inducers of the observed effects, are results of previous
studies of our lab showing that the adverse affects of FOS
on mucosal barrier, i.e. increased permeability and
decreased resistance to pathogens, are absent when cal-
cium is supplemented to the diets [4]. Calcium is known
to increase the buffering capacity of luminal contents by
its precipitation with dietary phosphate. By preventing
acidification during fermentation, SCFA will remain in
the anionic form, for which the cellular plasma mem-
brane is not permeable. Other possible mechanisms may
play a role, including SCFA induced accumulation of Acyl
CoA in mitochondria, opening of the pore complex or
modulation of histone deacetylase activity by butyrate fol-
lowed by an altered PGC1 expression, but none of these
mechanisms were supported by consistent changes in
gene expression.
The second major process affected by FOS was protein
turnover. FOS induced 27 ribosomal proteins and 30 pro-
teasomal genes, indicating increased protein turnover.
Intracellular proteins are targeted to the proteasomal deg-
radation system by ubiquitination [52]. Proteasomal deg-
radation is tightly controlled and removes denatured,
misfolded and damaged proteins. The clear increase in
proteasomal gene expression might result from increased
presence of misfolded proteins. One common cause of
misfolding of cellular proteins is mild oxidative stress
[53]. FOS induced several genes related to oxidative stress,
such as metallothionein-2 (Mt2) metallothionein-1a
(Mt1a), six glutathione S-transferases (Gst's), heme oxyge-
nase 1 (Hmox1), and superoxide dismutase 1 and 3 (Sod1
and Sod3). An increase in oxidative stress proteins is an
indirect marker for production of reactive oxygen species
(ROS) [54]. It is well recognized that induced mitochon-
drial activity can increase production of ROS. The
increased expression of oxidative stress genes and mito-
chondrial genes observed in the present study suggests
increased mitochondrial activity, possibly associated with
increased ROS production and increased protein oxida-
tion. Oxidized proteins are often misfolded, and directed
to proteasomes for degradation. In support, the translo-
case Sec61 responsible for intracellular transport of mis-
folded proteins from the ER to the proteasome was
significantly increased 1.4 fold (p < 0.001) by FOS.
Increased proteasomal gene expression might also reflect
the formation of immunoproteasomes (I-proteasomes)
[55]. The I-proteasome plays a role in antigen processing
and is composed of two subunits PSME1 and PSME2 [55]
which were both significantly increased by FOS supple-
mentation. Expression of these subunits is known to be
induced by microbial infection and cytokines like IFNγ
[56]. Alterations in the I-proteasome in the injured intes-
tinal epithelium are observed in colon biopsies of IBD
patients and IBD-mouse models [55,57]. The increased
intestinal permeability due to the FOS diet can cause
increased exposure of the mucosa to bacteria and there-
fore induce I-proteasome gene expression.
The top 10 most significantly changed genes by FOS
showed to be good representatives of the major biological
processes selected from pathway analysis. In addition to
genes related to mitochondria and protein turnover, two
genes coding for cellular retinol-binding proteins (Rbp7
and Rbp2) were highly induced by FOS. RBPs are required
for uptake, intracellular transport and metabolism of vita-
min A. Vitamin A is a fat-soluble vitamin necessary for
growth and differentiation of epithelial tissues. RBP7 and
RBP2 belong to the fatty-acid binding protein (FABP)
family. FOS also significantly increased Fabp1 2.9 fold. At
present, we cannot explain the FOS induced expression of
these genes and its relation to the functional effects
observed in this and our earlier FOS studies.
Proglucagon is one of the most highly induced gene by
FOS (2.6-fold, p < 0.001). The proglucagon gene is a pre-
cursor encoding several glucagon-like peptides. In intesti-
nal enteroendocrine cells the gene codes for
oxyntomodulin, GLP1 and GLP2 [58]. This gene was pre-
viously found to be induced by non-digestible oligosac-
charides [59]. Besides FOS induced expression of
proglucagon, FOS induced the expression of several other
gut-derived peptide hormones, namely cholecystokinin
(Cck), peptide YY (Pyy) and pancreatic polypeptide (Ppy).
Increase of PYY has previously been reported in rat colon
by SCFA [60]. Proglucagon, PYY, PPY and CCK are all
expressed by enteroendocrine L cells in colon and play a
role in gut-nutrient sensing [61]. In the hypothalamus
nutrient sensing is also regulated by these hormones and
directly related to ATP status [62]. It is speculated that the
same mechanism is applicable to enteroendocrine L cells
in de gut [60]. Since in our study, increased gene expres-
sion of these 4 peptide hormone genes coincides with
alterations in mitochondrial processes, it is tempting to
speculate that these hormones also influence or respond
to energy metabolism in intestinal epithelial cells. Besides
a role in energy homeostasis, GLP-2, PYY and CCK have
growth-promoting properties on the intestinal epithelium
in vivo [63]. GLP1 stimulated cell proliferation has been
reported for liver and pancreas [64]. GLP2 is involved inBMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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regulation of mucosal epithelial integrity) [65]. It stimu-
lates intestinal crypt cell proliferation [66] and reduces
apoptosis, therefore enhances mucosal regeneration. It
has beneficial effects on many causes of intestinal injury,
such as stress, vascular ischemia, NSAID administration
and chemically induced injury in rodents, and decreases
subsequent intestinal permeability [67,68]. The upregula-
tion of these genes might thus be a response to the
impaired intestinal barrier in FOS-fed rats.
FOS consistently increased intestinal permeability, but
the present study showed hardly any effect on expression
of well known intestinal integrity genes in the colon. Most
surprisingly no changes were observed in genes related to
tight junctions that were expected since tight junctions are
key regulators of paracellular transport. However, changes
in epithelial permeability are a result of internalization of
the tight-junction proteins occludin, claudin and junc-
tional adhesion molecule-A [69]. These cellular transloca-
tions can occur without concomitant changes in mRNA
gene expression. Detection of such effects would require a
different approach from transcriptomics. Immunohisto-
chemistry could show whether translocation of TJ pro-
teins occurred in the FOS fed rats compared with control
fed rats and is under current investigation.
Conclusion
Altogether we show that altered barrier integrity induced
by dietary FOS in rats coincides with a clear increase in
colonic mitochondrial gene expression, suggesting that
mitochondrial energy metabolism is important for main-
taining the intestinal barrier. The role of mitochondria in
maintenance of the intestinal barrier is accepted in NSAID
and DNP uncoupling studies. We speculate that FOS
induced excess production of SCFA and acidification of
luminal contents might result in SCFA induced ATP deple-
tion of colonic epithelial cells. Insight into the role of
mitochondrial function and ATP depletion is of relevance,
not only for the application of FOS and other prebiotics
in food products on the current market, but especially for
mechanistic understanding of intestinal disorders where
gut permeability changes are observed.
Methods
Animals and diet
The animal welfare committee of Wageningen University
(Wageningen, the Netherlands) approved the experimen-
tal protocol. Specific pathogen-free male outbred Wister
rats (8 weeks old, mean body weight of 253 g; n = 36 in
total), were housed individually in metabolic cages. All
animals were kept in a temperature (22–24°C) and
humidity (50–60%) controlled room with a 12 h light/
dark cycle (lights on from 6 AM to 6 PM). Rats (two die-
tary groups, n = 18 each) were fed restricted quantities (14
g/day) of a purified diet during the entire experimental
period. Restricted food intake was necessary to prevent
differences in food consumption and hence differences in
vitamin and mineral intake as observed earlier in FOS
interventions [3]. The diet contained (per kg) 200 g acid
casein, 502 g glucose, 160 g palm oil, 40 g corn oil, 20 g
cellulose, 35 g mineral mix (without calcium) and 10 g
vitamin mix according to AIN93 recommendations [70].
Diets contained 20 g/kg cellulose at least and were supple-
mented with either 60 g/kg FOS (purity 93%; Raftilose
P95, Orafti, Tienen, Belgium) or additional 60 g/kg cellu-
lose as described earlier [3]. Diets were low in calcium (20
mmol CaHPO4.2H2O/kg) and high in fat content (200 g
fat/kg) to mimic the composition of a Western human
diet. Demineralized drinking water was supplied ad libi-
tum.
To follow intestinal permeability, 6 of the 18 rats of each
dietary group received their diet supplemented with the
intestinal permeability marker chromium ethylenedi-
amine-tetraacetic acid (CrEDTA). The CrEDTA solution
added to the diet was prepared as described elsewhere [5].
After feeding the diets for 16 days, rats were killed by car-
bon dioxide inhalation. Rats fed diets containing the per-
meability marker CrEDTA (n = 6 per diet group) were not
included in the gene expression study, to exclude possible
interaction of CrEDTA on colonic gene expression. From
the remaining 12 rats per dietary group, the colon was
taken out, longitudinally opened and colonic contents
were removed by a quick rinse in 154 mM KCl. Colonic
mucosa was scraped off using a spatula. Scrapings were
immediately frozen in liquid nitrogen and stored at -
80°C. The scrapings were homogenized in liquid N2 using
a mortar and pestle cooled with liquid N2 (Fisher Emergo,
Landsmeer, The Netherlands). One third of the pulverized
samples was used for protein determination and the
remaining part for RNA isolation.
Analysis of urine samples
Total 24 h urine samples were collected on days 14 and 15
from rats fed the control and FOS diet (n = 6 each) supple-
mented with CrEDTA. Urines were preserved by adding
oxytetracycline (1 mg) to the urine collection vessels of
the metabolic cages, and analyzed for the intestinal per-
meability marker CrEDTA as described elsewhere [5].
CrEDTA data were analyzed using the Student's t-test
(two-sided) using Prism 4 (GraphPad software Inc., San
Diego, CA).
RNA isolation
Total RNA was isolated from colon scraping homogenates
using TRIzol reagent (Invitrogen, San Diego, CA) accord-
ing to the manufacturer's instructions. Total RNA was
purified using Rneasy columns (Qiagen, Chatsworth,
CA). Absence of RNA degradation was checked on a 1%
TBE/agarose gel after 1 hour incubation at 37°C. RNABMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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purity and concentration were measured with the Nano-
drop (Isogen Life Science, Maarssen, The Netherlands).
OD A260/A280 ratios were all between 2.08 and 2.10 indi-
cating RNA of high purity.
Analysis of mRNA expression by Oligo Arrays
For microarray hybridization, RNA of each individual ani-
mal was labeled with Cy-5. A standard reference sample,
consisting of a pool of all colonic RNA was labeled with
Cy-3. For each oligo array, 35 µg of total RNA was used to
make Cy-5 or Cy-3 labeled cDNA. Total RNA was mixed
with 4 µg T21 primer, heated at 65°C for 3 min (RNA
denaturation) followed by 25°C for 10 min (primer
annealing). cDNA was synthesized by adding 5× first
strand buffer (Invitrogen), 10 mM DTT, 0.5 mM dATP, 0.5
mM dGTP, 0.5 mM dTTP, 0.04 mM dCTP, 0.04 mM Cy5-
dCTP or Cy3-dCTP, 1.2 U RnaseOUT and 6 U SuperScript
II Reverse Transcriptase to a total volume of 62.5 µL. The
reaction was incubated at 42°C for 2 h. Purification, pre-
cipitation and denaturation of the labeled cDNA were per-
formed as previously described [71].
Each labeled cDNA sample was individually hybridized
on the 44 K rat whole genome Agilent array (G4131A, Agi-
lent Technologies, Inc. Santa Clara, CA) consisting of
44290 60-mer rat oligonucleotide probes, including
~3000 control spots. The Cy5 labeled cDNAs of the indi-
vidual rats were mixed 1:1 with the Cy3 labeled reference
cDNA, mixed with 2× hybridization buffer (Agilent Tech-
nologies) and 10× control targets (Agilent Technologies)
and hybridized for 17 hours at 60°C in Agilent hybridiza-
tion chambers in an Agilent hybridization oven rotating at
4 rpm (Agilent Technologies). After hybridization the
arrays were washed with an SSPE wash procedure (Agilent
Technologies) and scanned with a Scanarray Express HT
scanner (Perkin Elmer).
Data analyses and functional interpretation of microarray 
data
Spot intensities were quantified using ArrayVision 8.0 (GE
Healthcare life sciences). Median density values and back-
ground values of each spot were extracted for both the
experimental samples (Cy5) and the reference samples
(Cy3). Subsequently, quality control was performed for
each microarray using both LimmaGUI package in R from
Bioconductor and Microsoft Excel. One array in the die-
tary FOS group did not pass the quality control based on
MA plot and signal intensity distribution [72]. Therefore,
the dataset contained 23 arrays in total. Data was exported
into GeneMaths XT (Applied Maths, Sint-Martens-Latem,
Belgium) for background correction and normalization.
We discarded spots with an average intensity, over all
arrays, of Cy5 lower than 1.5-fold above average back-
ground. Then, the Cy5 intensities were normalized against
the Cy3 reference as described previously [73]. The data
have been deposited in NCBIs Gene Expression Omnibus
[74] and are accessible through GEO Series accession
number GSE5943. The complete dataset is available in
Additional files 4 and 5. Fold changes calculations were
performed in Microsoft Excel, fold change equals ratio
FOS/control in the case of increase or equals -1/ratio in
the case of decrease. For statistical identification of differ-
entially regulated probes between the control and FOS
group we used two complementary tests, the often used t-
test and Random Forest (RF). T-test was performed in
GeneMaths XT, the generated p-values were used to
obtain insight into significantly affected genes. To correct
for multiple testing we used FDR-adjusted p-values (Gen-
eMaths XT), so called q-values [75]. For t-test we choose a
stringent threshold of p < 0.001. The corresponding q-
value was 0.035, meaning that 3.5% of the genes selected
by this p-value could be false positive. The t-test tests each
gene independently and therefore will miss genes that
have no main effect but are related to the treatment in
gene-gene interaction [76]. We therefore used RF, availa-
ble as R-package [77,78], as a complementary method as
that method includes genes that in gene-gene interaction
are related to treatment besides including genes with a
main treatment effect. RF was recently successfully used in
several microarray studies [19,20]. The method provides
an importance index for each gene. This value is depend-
ent on the main treatment effect of a gene. In addition,
gene-gene interaction related to the treatment increases
importance index value of genes [20]. For RF we defined a
threshold where the importance index of each gene in the
real dataset exceeded the importance index of genes
obtained from analysis of 100 randomly permuted data-
sets, using randomly assigned class labels FOS or control.
This indicates that these genes are truly related to the treat-
ment [79] (detailed method described in [80]). We
included the genes that were selected by the t-test thresh-
old and the genes selected by the RF threshold. These
genes were considered significantly changed by FOS.
To interpret functional changes in the dataset, we applied
two pathway analysis programs, Metacore and GSEA, with
different complementary pathway-classification proper-
ties. Pathway analysis of the selected genes was performed
using MetaCore (GeneGo Inc, St. Joseph, MI). We used
classification based on GO-term and classification based
on GeneGo annotation. The GeneGo annotation database
is a curated database of gene networks based on several
databases (KEGG, GO) and scientific literature [21]. We
also performed a pathway analysis with GSEA (Broad
Institute), a method that does not require preselection of
genes by a statistical threshold but uses the whole dataset.
GSEA is thoroughly described by Subramanian et al [81].
This method prevents possible selection bias [82,83]. We
used the c2 functional genesets based on publicly availa-
ble and curated databases (GenMapp, Biocarta and Sig-BMC Genomics 2008, 9:144 http://www.biomedcentral.com/1471-2164/9/144
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maAldrich). Only processes with 5–500 genes were taken
into account. Agilent gene annotation version 20060331
was used for both programs. We selected pathways with p
< 0.001 in metacore and q-value < 0.25 in GSEA, in
accordance with the recommendation of the GSEA devel-
opers [81].
Since only about 30% of the genes on the whole genome
array were recognized in both pathway programs, we
manually supplemented the significantly enriched biolog-
ical processes with non-annotated genes from the selected
gene-set using biological databases (Biocarta, SOURCE,
GenMAPP, KEGG) and scientific literature. As processes
overlap, we bundled some processes and renamed them.
Analysis of mRNA expression by Real-time Quantitative 
RT-PCR
Real-time Quantitative RT-PCR (Q-PCR) was performed
on individual samples (n = 12 per group). 1 µg of RNA of
all individual samples was used for cDNA synthesis using
the iScript cDNA synthesis kit of Bio-Rad Laboratories
(Veenendaal, The Netherlands). Real-time reactions were
performed by means of the iQ SYBR Green Supermix of
Bio-Rad using the MyIQ single-color real-time PCR detec-
tion system (Bio-Rad). Each reaction (25 µl) contained
12.5 µl iQ SYBR green supermix, 1 µl forward primer (10
µM), 1 µl reverse primer (10 µM), 8.5 µl RNase-free water
and 2 µl diluted cDNA. The following cycles were per-
formed: 1 × 3 min at 95°C, 40 amplification cycles (40 ×
10 s 95°C, 45 s 60°C), 1 × 1 min 95°C, 1 × 1 min 62°C
and a melting curve (80 × 10 s 55°C with an increase of
0.5°C per 10 s). A negative control without cDNA tem-
plate was run with every assay. The optimal melting point
of dsDNA (Tm) and the efficiency of the reaction were
optimized beforehand. Data were normalized against the
reference genes Pleckstrin homology domain containing,
family A member 6 (Plekha6), Nucleoporin 37 (Nup37)
and β-actin. Plekha6 and Nup37 were chosen because our
microarray data showed equal expression levels for all
microarrays, and β-actin was chosen because it is a well
accepted reference gene. Primers were designed using Bea-
con designer 7.00 (Premier Biosoft International, Palo
Alto, CA). For primer sequences see Additional file 6. A
standard curve for all genes, including reference genes,
was generated using serial dilutions of a pooled sample
(cDNA from all reactions). mRNA levels were determined
using delta CT method (IQ5 software version 2.0, Bio-Rad
version). Analysis of all individual samples was per-
formed in duplicate. Data were analyzed using Student's
t-test (two-sided) using Prism 4. Differences were consid-
ered statistically significant when p < 0.05.
Protein determination
Mucosal scrapings of individual rats or pools of all rats per
group (n = 12) were lysed in a buffer containing 0.125 M
TrisHCl pH 6.8, 2% SDS and 20% glycerol. Protein con-
centrations were determined using DC protein assay kit
(Bio-rad Laboratories, Veenendaal, the Netherlands). All
samples were boiled in sample buffer (0.125 M TrisHCl
pH 6.8; 2% SDS; 20% glycerol; 2% β-mercaptoethanol;
0.04% coomassie briljant blue), and separated by 14%
SDS-PAGE. The proteins were transferred onto a nitrocel-
lulose membrane. Immunoblot analysis was performed
with a 1:2000 dilution monoclonal antibodies against
OXPHOS complexes, Complex IV subunit II (COXII)
monoclonal antibody (MS601, Mitosciences, Eugene, OR,
USA) or with a 1:200 dilution of monoclonal anti-GLP1
antibody (Abcam (Ab23468), Cambridge, UK) by incuba-
tion in 2.5% protifar/TBS-T for 1 1/2 hr at RT. After incu-
bation, blots were washed in TBS-T and incubated 1 hr at
RT with a 1:2000 dilution horseradish peroxidase-conju-
gated anti-mouse IgG (7076, Cell Signaling, Danvers, MA,
USA) for detection GLP1 or a 1:2500 dilution of horserad-
ish peroxidase-conjugated anti-mouse IgG (W4021,
Promega, Madison, WI, USA) for detection of Complex
IV. The signal was detected using an enhanced chemilumi-
nescence detection system (GE Healthcare, The Nether-
lands) according to the protocol of the supplier. After
washing the membranes thoroughly with TBS-T, they
were subsequently incubated with the monoclonal anti-
Actin (1:100 dilution, Santa Cruz, sc-1615) and HRP anti-
goat (1:10000 dilution, Promega. V8051). The intensities
of GLP-1, COXII and actin signals on the autoradiography
films were quantified using geldoc (Bio-Rad). GLP-1 and
COXII quantities were normalized to actin to correct for
loading differences.
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